XML 21 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Apr. 30, 2018 1,648 55,689      
Beginning balance, value at Apr. 30, 2018 $ 2 $ 55 $ 614,810 $ (559,129) $ 55,738
Series E preferred stock dividends     (2,162)   (2,162)
Cumulative-effect adjustment to accumulated deficit pursuant to adoption of ASU       2,739 2,739
Common stock issued under Employee Stock Purchase Plan, shares   40      
Common stock issued under Employee Stock Purchase Plan, value     114   114
Exercise of stock options, shares   334      
Exercise of stock options, value   $ 1 1,157   1,158
Stock-based compensation expense     622   622
Net loss       (3,412) (3,412)
Ending balance, shares at Oct. 31, 2018 1,648 56,063      
Ending balance, value at Oct. 31, 2018 $ 2 $ 56 614,541 (559,802) 54,797
Beginning balance, shares at Jul. 31, 2018 1,648 55,990      
Beginning balance, value at Jul. 31, 2018 $ 2 $ 55 615,040 (558,351) 56,746
Series E preferred stock dividends     (1,081)   (1,081)
Common stock issued under Employee Stock Purchase Plan, shares   40      
Common stock issued under Employee Stock Purchase Plan, value     114   114
Exercise of stock options, shares   33      
Exercise of stock options, value   $ 1 143   144
Stock-based compensation expense     325   325
Net loss       (1,451) (1,451)
Ending balance, shares at Oct. 31, 2018 1,648 56,063      
Ending balance, value at Oct. 31, 2018 $ 2 $ 56 614,541 (559,802) 54,797
Beginning balance, shares at Apr. 30, 2019 1,648 56,136      
Beginning balance, value at Apr. 30, 2019 $ 2 $ 56 613,615 (560,605) 53,068
Series E preferred stock dividends     (2,162)   (2,162)
Common stock issued under Employee Stock Purchase Plan, shares   47      
Common stock issued under Employee Stock Purchase Plan, value     187   187
Exercise of stock options, shares   127      
Exercise of stock options, value     431   431
Vesting of restricted stock units   28      
Stock-based compensation expense     1,254   1,254
Net loss       (3,594) (3,594)
Ending balance, shares at Oct. 31, 2019 1,648 56,338      
Ending balance, value at Oct. 31, 2019 $ 2 $ 56 613,325 (564,199) 49,184
Beginning balance, shares at Jul. 31, 2019 1,648 56,238      
Beginning balance, value at Jul. 31, 2019 $ 2 $ 56 613,395 (563,769) 49,684
Series E preferred stock dividends     (1,081)   (1,081)
Common stock issued under Employee Stock Purchase Plan, shares   47      
Common stock issued under Employee Stock Purchase Plan, value     187   187
Exercise of stock options, shares   53      
Exercise of stock options, value     173   173
Stock-based compensation expense     651   651
Net loss       (430) (430)
Ending balance, shares at Oct. 31, 2019 1,648 56,338      
Ending balance, value at Oct. 31, 2019 $ 2 $ 56 $ 613,325 $ (564,199) $ 49,184